Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes

Drug Metabolism and Disposition

Volumn 33, Issue 3, 2005, Pages 388-394

  Annaert, Pieter P ^a,b   Brouwer, Kim L R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DEXVERAPAMIL; DIGOXIN; ESTRADIOL 17 GLUCURONIDE; GLYCOPROTEIN P; PROGESTERONE; QUERCETIN; QUININE; RHODAMINE 123; RIFAMPICIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG TRANSPORT; DRUG UPTAKE; HEPATOBILIARY SYSTEM; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGENASES; DIGOXIN; DRUG INTERACTIONS; HEPATOCYTES; MALE; P-GLYCOPROTEIN; PROGESTERONE; QUERCETIN; QUINIDINE; RATS; RATS, WISTAR; RHODAMINE 123; VERAPAMIL;

EID: 14044265064     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.001669     Document Type: Article

References (32)

1. Altenberg GA, Vanoye CG, Horton JK, and Reuss L (1994) Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane. Proc Natl Acad Sci USA 91:4654-4657.
2. Annaert PP, Turncliff R, Booth C, Thakker DR, and Brouwer KLR (2001) P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos 29:1277-1283.
3. Chieli E, Romiti N, Cervelli F, and Tongiani R (1995) Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci 57:1741-1751.
4. Cho C-W, Liu Y, Yan X, Henthorn T, and Ng K-Y (2000) Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research. Biochem Biophys Res Commun 279:124-130.
5. Conseil G, Baubichon-Cortay H, Dayan G, Jault J-M, Barron D, and Di Pietro A (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95:9831-9836.
6. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, and Kim RB (1999) OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866-871.
7. 2,5]- enkephalin at the murine blood-brain barrier by in situ perfusion. Neurosci Lett 301:155-158.
8. Doppenschmitt S, Spahn-Langguth H, Regårdh CG, and Langguth P (1999) Role of P-glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein. J Pharm Sci 88:1067-1072.
9. Fardel O, Lecureur V, Loyer P, and Guillouzo A (1995) Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. Biochem Pharmacol 49:1255-1260.
10. Fattinger K, Cattori V, Hagenbuch B, Meier PJ, and Stieger B (2000) Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. Hepatology 32:82-86.
11. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, and Kroemer HK (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Investig 104:147-153.
12. Hamman MA, Bruce MA, Haehner-Daniels BD, and Hall SD (2001) The effect of rifampin administration on the disposition of fexofenadine. Clin Pharmacol Ther 69:114-121.
13. Hanafy A, Langguth P, and Spahn-Langguth H (2001) Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats. Eur J Pharm Sci 12:405-415.
14. Hedman A, Angelin B, Arvidsson A, Dahlqvist R, and Nilsson B (1990) Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine. Clin Pharmacol Ther 47:20-26.
15. Johnson LV, Walsh ML, Bockus BJ, and Chen LB (1981) Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol 88:526-535.
16. Kusuhara H and Sugiyama Y (2001) Drug-drug interactions involving the membrane transport process. Drugs Pharm Sci 116:123-188.
17. Larson DA (1992) Analysis of variance with just summary statistics as input. Am Stat 46:151-152.
18. Liu X, Chism JP, LeCluyse EL, Brouwer KR, and Brouwer KLR (1999) Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637-644.
19. Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, and Sawada Y (2000) Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol 395:193-201.
20. Noé B, Hagenbuch B, Stieger B, and Meier PJ (1997) Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA 94:10346-10350.
21. Phang JM, Poore CM, Lopaczynska J, and Yeh GC (1993) Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53:5977-5981.
22. Reichel C, Gao B, Van Montfoort J, Cattori V, Rahner C, Hagenbuch B, Stieger B, Kamisako T, and Meier PJ (1999) Localization and function of the organic anion-transporting polypeptide oatp2 in rat liver. Gastroenterology 117:688-695.
23. Sababi M, Borga O, and Hultkvist-Bengtsson U (2001) The role of P-glycoprotein in limiting intestinal absorption of digoxin in rats. Eur J Pharm Sci 14:21-27.
24. Schuetz EG, Beck WT, and Schuetz JD (1996) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311-318.
25. Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
26. Shapiro AB and Ling V (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250:130-137.
27. Silverman JA and Schrenk D (1997) Expression of the multidrug resistance genes in the liver. FASEB J 11:308-312.
28. Stephens RH, O'Neill CA, Warhurst A, Carlson GL, Rowland M, and Warhurst G (2001) Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 296:584-591.
29. Sugiyama D, Kusuhara H, Shitara Y, Abe T, and Sugiyama Y (2002) Effect of 17β-estradiol-D-17β-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. Drug Metab Dispos 30:220-223.
30. Thiebaut F, Tsuro T, Hamada H, Gottesman MM, Pastan I, and Willingham MC (1987) Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738.
31. Troutman MD and Thakker DR (2003) Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. Pharm Res (NY) 20:1192-1199.
32. Turncliff RZ, Meier PJ, and Brouwer KLR (2004) Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metab Dispos 32:834-839.